BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4795224)

  • 1. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
    Chirigos MA; Pearson JW; Pryor J
    Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride.
    Chirigos MA; Fuhrman F; Pryor J
    Cancer Res; 1975 Apr; 35(4):927-31. PubMed ID: 1116150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the immunostimulants levamisole and tetramisole.
    Spreafico F; Vecchi A; Mantovani A; Poggi A; Franchi G; Anaclerio A; Garattini S
    Eur J Cancer (1965); 1975 Aug; 11(8):555-63. PubMed ID: 1222762
    [No Abstract]   [Full Text] [Related]  

  • 5. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 6. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
    Johnson RK; Houchens DP; Gaston MR; Goldin A
    Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
    Delfina Pesce C; Boccanera M; Marconi P; Bistoni F; Cenci E; Tissi L; Cassone A
    Ann Ist Super Sanita; 1982; 18(3):509-12. PubMed ID: 7187836
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of host response to levamisole after chemotherapy in a murine leukemia.
    Perk K; Chirigos MA; Fuhrman F; Pettigrew H
    J Natl Cancer Inst; 1975 Jan; 54(1):253-6. PubMed ID: 1113305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor.
    Mohr SJ; Chirigos MA; Fuhrman FS; Pryor JW
    Cancer Res; 1975 Dec; 35(12):3750-4. PubMed ID: 1192431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined chemoimmunostimulation therapy against murine leukemia.
    Pearson JW; Pearson GR; Gibson WT; Chermann JC; Chirigos MA
    Cancer Res; 1972 May; 32(5):904-7. PubMed ID: 4552917
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
    Perito S; Cenci E; Sbaraglia G; Vecchiarelli A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F
    Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunostimulation in chronic lymphocytic leukemia (author's transl)].
    Konopka L; Zywicka-Lopaciuk H; Sylwestrowicz T; Karpowicz M; Cieśluk S; Maślanka K; Pawelski S
    Przegl Lek; 1981; 38(5):437-41. PubMed ID: 7268042
    [No Abstract]   [Full Text] [Related]  

  • 18. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief communication: Cure of murine leukemia with drug and interferon treatment.
    Chirigos MA; Pearson JW
    J Natl Cancer Inst; 1973 Oct; 51(4):1367-8. PubMed ID: 4745868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.